Summary COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of
symptom severity that requires varying amounts of care according to the different stages of …

Abstract The coronavirus disease 2019 (COVID-19) caused by coronavirus SARS-CoV-2
infection has become a global pandemic due to the high viral transmissibility and …

The presence of symptoms after an acute SARS-CoV-2 infection (long-COVID) has become
a worldwide healthcare emergency but remains underestimated and undertreated due to a …

At the start of the coronavirus disease 2019 (COVID-19) pandemic (March 2020), there was
speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, used to …

Background Pain after a SARS‐CoV‐2 acute infection (post‐COVID pain) is becoming a
new healthcare emergency but remains underestimated and most likely undertreated due to …

Angiotensin-converting enzyme 2 (ACE2), first discovered in 2000, serves as an important
counterregulatory enzyme to the angiotensin II-mediated vasoconstrictive, pro-inflammatory …

The severity of adenovirus infection or the success of adenovirus-vectorized gene therapy
largely depends on the efficiency of viral entry into cells. Various drugs can alter viral entry …

Background It is known that severe acute respiratory coronavirus 2 (SARS-CoV-2) is the
viral strain responsible for the recent coronavirus disease 2019 (COVID-19) pandemic …

The SARS-CoV-2 coronavirus infects cells through the cellular receptor angiotensin-
converting enzyme 2 (ACE2), and the protease TMPRSS2 for the priming of viral spike …

Monkeypox (MPX) is a zoonotic infection caused by an orthopoxvirus that is endemic to
Central and Western Africa. The MPX virus is a part of the same family of viruses as the …